P21 suppresses cell proliferation and downregulates POLD1 expression in human gastric cancer cell line MGC-803

World Chinese Journal of Digestology

Volumn 19, Issue 19, 2011, Pages 1990-1995

  Ruan, Xi Ling ^a   Li, Yong Ji ^a   Wu, Qiong ^a   Liao, Liu Feng ^a   Xu, Heng ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Expression regulation; Gastric cancer; P21; Pold1

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN E; DNA POLYMERASE; DNA POLYMERASE POLD1; MESSENGER RNA; PROTEIN P21; PROTEIN RB1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL PROLIFERATION; CELL STRAIN MGC 803; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; ONCOGENE C MYC; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 80051541972     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v19.i19.1990     Document Type: Article

References (32)

1. DePamphilis ML. DNA Replication and Human Disease. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2006
2. Chinese Source
3. Chang LS, Zhao L, Zhu L, Chen ML, Lee MY. Structure of the gene for the catalytic subunit of human DNA polymerase delta (POLD1). Genomics 1995; 28: 411-419
4. Chinese Source
5. Chinese Source
6. Balakrishnan L, Gloor JW, Bambara RA. Reconstitution of eukaryotic lagging strand DNA replication. Methods 2010; 51: 347-357
7. Hindges R, Hübscher U. DNA polymerase delta, an essential enzyme for DNA transactions. Biol Chem 1997; 378: 345-362
8. Sweasy JB, Lauper JM, Eckert KA. DNA polymerases and human diseases. Radiat Res 2006; 166: 693-714
9. Schmitt MW, Venkatesan RN, Pillaire MJ, Hoffmann JS, Sidorova JM, Loeb LA. Active site mutations in mammalian DNA polymerase delta alter accuracy and replication fork progression. J Biol Chem 2010; 285: 32264-32272
10. Liu L, Mo J, Rodriguez-Belmonte EM, Lee MY. Identification of a fourth subunit of mammalian DNA polymerase delta. J Biol Chem 2000; 275: 18739-18744
11. Yang CL, Chang LS, Zhang P, Hao H, Zhu L, Toomey NL, Lee MY. Molecular cloning of the cDNA for the catalytic subunit of human DNA polymerase delta. Nucleic Acids Res 1992; 20: 735-745
12. Sanefuji K, Taketomi A, Iguchi T, Sugimachi K, Ikegami T, Yamashita Y, Gion T, Soejima Y, Shirabe K, Maehara Y. Significance of DNA polymerase delta catalytic subunit p125 induced by mutant p53 in the invasive potential of human hepatocellular carcinoma. Oncology 2010; 79: 229-237
13. Chinese Source
14. Jerry DJ, Tao L, Yan H. Regulation of cancer stem cells by p53. Breast Cancer Res 2008; 10: 304
15. Li B, Lee MY. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. J Biol Chem 2001; 276: 29729-29739
16. Gartel AL. p21(WAF1/CIP1) and cancer: a shifting paradigm? Biofactors 2009; 35: 161-164
17. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369: 574-578
18. Chinese Source
19. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9: 400-414
20. Chinese Source
21. Xia M, Knezevic D, Vassilev LT. p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation. Oncogene 2011; 30: 346-355
22. Chinese Source
23. Chinese Source
24. Plasilova M, Schonmeyr B, Fernandez J, Clavin N, Soares M, Mehrara BJ. Accelerating stem cell proliferation by down-regulation of cell cycle regulator p21. Plast Reconstr Surg 2009; 123: 149S-157S
25. Zhang H, Xiong Y, Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 1993; 4: 897-906
26. Fotedar R, Bendjennat M, Fotedar A. Functional analysis of CDK inhibitor p21WAF1. Methods Mol Biol 2004; 281: 55-71
27. Merrick KA, Wohlbold L, Zhang C, Allen JJ, Horiuchi D, Huskey NE, Goga A, Shokat KM, Fisher RP. Switching cdk2 on or off with small molecules to reveal requirements in human cell proliferation. Mol Cell 2011; 42: 624-636
28. Satyanarayana A, Hilton MB, Kaldis P. p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint. Mol Biol Cell 2008; 19: 65-77
29. Krucher NA, Zygmunt A, Mazloum N, Tamrakar S, Ludlow JW, Lee MY. Interaction of the retinoblastoma protein (pRb) with the catalytic subunit of DNA polymerase delta (p125). Oncogene 2000; 19: 5464-5470
30. Jung P, Menssen A, Mayr D, Hermeking H. AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci U S A 2008; 105: 15046-15051
31. Hwang-Verslues WW, Sladek FM. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol Endocrinol 2008; 22: 78-90
32. Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C, Quan L, Bai J, Xu N. Suppression of p21 by c-Myc through members of miR-17 family at the posttranscriptional level. Int J Oncol 2010; 37: 1315-1321